M A Nash

495 total citations
15 papers, 424 citations indexed

About

M A Nash is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, M A Nash has authored 15 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Immunology. Recurrent topics in M A Nash's work include Virus-based gene therapy research (5 papers), RNA Research and Splicing (5 papers) and Viral Infections and Immunology Research (3 papers). M A Nash is often cited by papers focused on Virus-based gene therapy research (5 papers), RNA Research and Splicing (5 papers) and Viral Infections and Immunology Research (3 papers). M A Nash collaborates with scholars based in United States. M A Nash's co-authors include Ralph S. Freedman, Ralph B. Arlinghaus, Chris D. Platsoucas, John J. Kavanagh, Amy Loercher, Edwin C. Murphy, Jacob V. Maizel, Danielle Konings, Glenn L. Decker and Richard C. Hamelin and has published in prestigious journals such as The Journal of Immunology, Analytical Biochemistry and Journal of Virology.

In The Last Decade

M A Nash

15 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M A Nash United States	11	216	165	89	75	66	15	424
Robert R. Getty United States	8	165 0.8×	247 1.5×	51 0.6×	69 0.9×	13 0.2×	8	442
Sam H. Whiting United States	9	153 0.7×	76 0.5×	141 1.6×	32 0.4×	14 0.2×	20	361
G Feuer United States	9	75 0.3×	209 1.3×	42 0.5×	72 1.0×	6 0.1×	13	345
Bratin K. Saha United States	11	169 0.8×	73 0.4×	60 0.7×	69 0.9×	5 0.1×	22	328
Elaine Kao United States	6	406 1.9×	151 0.9×	127 1.4×	23 0.3×	14 0.2×	8	597
K E Dolter United States	10	204 0.9×	88 0.5×	60 0.7×	90 1.2×	6 0.1×	11	368
Eynat Tabor Israel	10	187 0.9×	37 0.2×	87 1.0×	73 1.0×	21 0.3×	20	405
Sarah Van Scoy United States	6	188 0.9×	286 1.7×	183 2.1×	33 0.4×	24 0.4×	6	497
Kenneth Garson Canada	17	386 1.8×	123 0.7×	160 1.8×	209 2.8×	6 0.1×	28	708
Dawn O’Reilly United Kingdom	16	731 3.4×	146 0.9×	39 0.4×	94 1.3×	17 0.3×	19	952

Countries citing papers authored by M A Nash

Since Specialization

Citations

This map shows the geographic impact of M A Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Nash more than expected).

Fields of papers citing papers by M A Nash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M A Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Nash. The network helps show where M A Nash may publish in the future.

Co-authorship network of co-authors of M A Nash

This figure shows the co-authorship network connecting the top 25 collaborators of M A Nash. A scholar is included among the top collaborators of M A Nash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M A Nash. M A Nash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hu, Wei, Claire F. Verschraegen, Weixin Wu, et al.. (2002). Activity of ALRT 1550, a new retinoid, with interferon-gamma on ovarian cancer cell lines. International Journal of Gynecological Cancer. 12(2). 202–207. 6 indexed citations

Hu, Wei, Weiguo Wu, M A Nash, et al.. (2000). Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.. PubMed. 20(2A). 729–33. 16 indexed citations

Loercher, Amy, M A Nash, John J. Kavanagh, Chris D. Platsoucas, & Ralph S. Freedman. (1999). Identification of an IL-10-Producing HLA-DR-Negative Monocyte Subset in the Malignant Ascites of Patients with Ovarian Carcinoma That Inhibits Cytokine Protein Expression and Proliferation of Autologous T Cells. The Journal of Immunology. 163(11). 6251–6260. 144 indexed citations

Gordinier, Mary E., Rebecca Patenia, Lawrence B. Levy, et al.. (1999). Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma.. PubMed. 5(9). 2498–505. 25 indexed citations

Nash, M A, Renato Lenzi, Chris D. Platsoucas, & Ralph S. Freedman. (1998). RT-PCR quantitation of cytokine responses in vivo from specimens containing small numbers of cells during bioimmunotherapy. Journal of Immunological Methods. 219(1-2). 169–179. 11 indexed citations

Freedman, Ralph S., Jacqueline A. Gibbons, Martin Giedlin, et al.. (1996). Immunopharmacology and Cytokine Production of a Low-Dose Schedule of Intraperitoneally Administered Human Recombinant Interleukin-2 in Patients with Advanced Epithelial Ovarian Carcinoma. Journal of Immunotherapy. 19(6). 443–451. 12 indexed citations

Nash, M A, Chris D. Platsoucas, Bryan Wong, et al.. (1995). Transduction of rIL-2 Expanded CD4 ⁺ and CD8 ⁺ Ovarian TIL-Derived T Cell Lines with the G1Na (neo ^R ) Replication-Deficient Retroviral Vector. Human Gene Therapy. 6(11). 1379–1389. 4 indexed citations

Nash, M A, et al.. (1993). A subset of Pr65gag is nucleus associated in murine leukemia virus-infected cells. Journal of Virology. 67(3). 1350–1356. 41 indexed citations

Konings, Danielle, M A Nash, Jacob V. Maizel, & Ralph B. Arlinghaus. (1992). Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus. Journal of Virology. 66(2). 632–640. 62 indexed citations

10.

Herzog, Norbert K., M A Nash, Louis S. Ramagli, & R B Arlinghaus. (1990). v-mos protein produced by in vitro translation has protein kinase activity. Journal of Virology. 64(6). 3093–3096. 8 indexed citations

11.

Cizdziel, Paul E., M A Nash, Donald G. Blair, & Edwin C. Murphy. (1986). Molecular basis underlying phenotypic revertants of Moloney murine sarcoma virus MuSVts110. Journal of Virology. 57(1). 310–317. 13 indexed citations

12.

Nash, M A, et al.. (1985). Murine sarcoma virus ts110 RNA transcripts: origin from a single proviral DNA and sequence of the gag-mos junctions in both the precursor and spliced viral RNAs. Journal of Virology. 53(2). 624–633. 23 indexed citations

13.

Hamelin, Richard C., et al.. (1985). Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells. Journal of Virology. 53(2). 616–623. 23 indexed citations

14.

Nash, M A, et al.. (1984). S1 nuclease mapping of viral RNAs from a temperature-sensitive transformation mutant of murine sarcoma virus. Journal of Virology. 50(2). 478–488. 31 indexed citations

15.

Nash, M A, et al.. (1981). Molecular weight determination of glyoxalated RNA by sedimentation centrifugation. Analytical Biochemistry. 111(2). 376–384. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact